Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Sep 1;10(17):2478-81.
doi: 10.3748/wjg.v10.i17.2478.

Potential involvement of leptin in carcinogenesis of hepatocellular carcinoma

Affiliations

Potential involvement of leptin in carcinogenesis of hepatocellular carcinoma

Xiu-Jie Wang et al. World J Gastroenterol. .

Abstract

Aim: To investigate the potential involvement of leptin in carcinogenesis of hepatocellular carcinoma (HCC) and to elucidate the etiology, carcinogenesis and progress of HCC.

Methods: Expressions of Ob gene product, leptin and its receptor, Ob-R were investigated in 36 cases of HCC specimens and corresponding adjacent non-tumorous liver tissues with immunohistochemical staining. The effect of leptin on proliferation of Chang liver cell line and liver cancer cell line SMMC-7721 was studied with cell proliferation assay (MTT).

Results: Leptin expression was detected in 36 cases of adjacent non-tumorous liver tissues (36/36, 100%) with moderate (++) to strong (+++) intensity; and in 72.22%(26/36) of HCC with weaker (+) intensity (P<0.05). Thirty of 36 (83.33%) cases of adjacent non-tumorous liver tissues were positive for Ob-R, with moderate (++) to strong (+++) intensity. In HCC, 11/36 (30.56%) cases were positive, with weak (+) intensity (P<0.05). In cell proliferation assay, leptin inhibited the proliferation of Chang liver cells. The cell survival rate was 10-13% lower than that of the untreated cells (P>0.05). Leptin had little effect on the proliferation of liver cancer cells (P>0.05).

Conclusion: High level expression and decreased or absent expression of leptin and its receptor in adjacent non-tumorous liver cells and HCC cells, inhibitory effect of leptin on the proliferation of normal Chang liver cells and no effect of leptin on proliferation of liver cancer cells, may provide new insights into the carcinogenesis and progression of human HCC. It could be assumed that leptin acting as an inhibitor and/or promoter, is involved in the process of carcinogenesis and progress of human HCC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Expression of leptin in adjacent non-tumorous liver live cells (left) and absent expression in HCC cells (right). S-P immunohistochemical staining × 200.
Figure 2
Figure 2
Absent expression of leptin in HCC cells, Kupffer cells and vascular endothelial cells expressed high levels of leptin. S-P immunohistochemical staining × 400.
Figure 3
Figure 3
Effect of leptin at different concentrations (ng/mL) on proliferation of Chang liver cells and liver cancer cells on d 5 (MTT assay). A: Effect of leptin at different concentrations (ng/mL) on proliferation of Chang liver cells on d 5 (MTT assay), B: Effect of leptin at different concentrations (ng/mL) on proliferation of liver cancer cells on d 5 (MTT assay).

Similar articles

Cited by

References

    1. Sierra-Honigmann MR, Nath AK, Murakami C, García-Cardeña G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, et al. Biological action of leptin as an angiogenic factor. Science. 1998;281:1683–1686. - PubMed
    1. Somasundar P, Yu AK, Vona-Davis L, McFadden DW. Differential effects of leptin on cancer in vitro. J Surg Res. 2003;113:50–55. - PubMed
    1. Onuma M, Bub JD, Rummel TL, Iwamoto Y. Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase. J Biol Chem. 2003;278:42660–42667. - PubMed
    1. Janeckova R. The role of leptin in human physiology and pathophysiology. Physiol Res. 2001;50:443–459. - PubMed
    1. Stephenson GD, Rose DP. Breast cancer and obesity: an update. Nutr Cancer. 2003;45:1–16. - PubMed

Publication types

MeSH terms